Jones, Gareth T.Dean, Linda E.Pathan, EjazHollick, Rosemary J.Macfarlane, Gary J.2020-04-272020-04-272020-07Jones, G T, Dean, L E, Pathan, E, Hollick, R J & Macfarlane, G J 2020, 'Real-world evidence of TNF inhibition in axial spondyloarthritis : can we generalise the results from clinical trials?', Annals of the Rheumatic Diseases, vol. 79, no. 7, pp. 914-919. https://doi.org/10.1136/annrheumdis-2019-2168410003-4967ORCID: /0000-0003-2322-3314/work/73119670ORCID: /0000-0001-6558-7189/work/79062974ORCID: /0000-0003-0016-7591/work/83703972https://hdl.handle.net/2164/14166Funding This work was supported by the British Society for Rheumatology (BSR) who funded the BSRBR-AS. The BSR received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments but have no input in to the topics for analysis in the register nor the work involved in undertaking analysis. Analysis of data was supported by the Versus Arthritis/Medical Research Council Centre for Musculoskeletal Health and Work (grant number 20665).6294958engankylosing spondylitisanti-TNFepidemiologyspondyloarthritisBSRANKYLOSING-SPONDYLITISBATHR Medicine (General)General Biochemistry,Genetics and Molecular BiologyImmunology and AllergyRheumatologyImmunologyMedical Research Council (MRC)20665Arthritis Research UK (ARUK)R1Journal article10.1136/annrheumdis-2019-216841http://www.scopus.com/inward/record.url?scp=85083707435&partnerID=8YFLogxK797